Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis
(PVTT) is very poor. This study aimed to evaluate hepatic arterial infusion chemotherapy
(HAIC) versus sorafenib (SORF) in the treatment of HCC with PVTT.